NCT02637037
- Conditions
- Bioequivalence, Diabetes Mellitus, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- Research Site Baltimore, Maryland, United States
Clinical trial condition
Explore clinical trials studying Fixed Dose Combination Tablets. Study availability and eligibility vary by location and protocol.
NCT02637037